MEHLMAN CONSULTING, INC. for ASTRAZENECA PHARMACEUTICALS
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Budget issues, including Medicare Part D Rebates. Discussions and possible legislation amending Title XVIII, Part D (Medicare Part D) of SSA, including issues of "non-interference clause," protected classes of drugs, and Medicare Advantage. Legislation to address physician payments issues, including SGR and related provisions to Medicare package. Health reform implementation. Independent Payment Advisory Board. Budget Control Act of 2011 (Became PL 112-25 on August 2, 2011)
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY RUCKER BINGEL | — |
| CYNTHIA BROWN | — |
| DAVID CASTAGNETTI | — |
| COLETTE DESMARAIS | — |
| ELISE FINLEY PICKERING | — |
| JONATHAN RUSSELL HOGANSON | — |
| BRUCE MEHLMAN | — |
| STACEY RAMPY | — |
| DEAN ROSEN | — |
| DAVID R THOMAS | — |
| ALLEN L THOMPSON | — |
| ALEX VOGEL | — |
| BRIAN WILD | — |
Trade (domestic/foreign) TRD
International trade issues, including free-trade agreements; import safety.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY RUCKER BINGEL | — |
| CYNTHIA BROWN | — |
| DAVID CASTAGNETTI | — |
| COLETTE DESMARAIS | — |
| ELISE FINLEY PICKERING | — |
| JONATHAN RUSSELL HOGANSON | — |
| BRUCE MEHLMAN | — |
| STACEY RAMPY | — |
| DEAN ROSEN | — |
| DAVID R THOMAS | — |
| ALLEN L THOMPSON | — |
| ALEX VOGEL | — |
| BRIAN WILD | — |
Taxation/Internal Revenue Code TAX
Tax issues, including repatriation, deferral and carried interest.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY RUCKER BINGEL | — |
| CYNTHIA BROWN | — |
| DAVID CASTAGNETTI | — |
| COLETTE DESMARAIS | — |
| ELISE FINLEY PICKERING | — |
| JONATHAN RUSSELL HOGANSON | — |
| BRUCE MEHLMAN | — |
| STACEY RAMPY | — |
| DEAN ROSEN | — |
| DAVID R THOMAS | — |
| ALLEN L THOMPSON | — |
| ALEX VOGEL | — |
| BRIAN WILD | — |
Health Issues HCR
Health care reform: implementation issues, including pharmaceutical taxes, Medicaid changes, and comparative effectiveness. H.R. 2182, Generating Antibiotic Incentives Now (GAIN) Act. Prescription Drug User Fee Act (PDUFA)
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY RUCKER BINGEL | — |
| CYNTHIA BROWN | — |
| DAVID CASTAGNETTI | — |
| COLETTE DESMARAIS | — |
| ELISE FINLEY PICKERING | — |
| JONATHAN RUSSELL HOGANSON | — |
| BRUCE MEHLMAN | — |
| STACEY RAMPY | — |
| DEAN ROSEN | — |
| DAVID R THOMAS | — |
| ALLEN L THOMPSON | — |
| ALEX VOGEL | — |
| BRIAN WILD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.